PEPID Pulse
  • Blog
  • Alerts
  • Press
  • pepid.com
Select Page

First Treatment for Post-partum Depression FDA Approved

by PEPID Newsroom | Mar 19, 2019 | Alerts

Tuesday, March 19, the FDA approved Zulresso (brexanolone) injection for intravenous (IV) use to treat post-partum depression (PPD) in adult women. No other drug before now has been approved to specifically treat PPD. Zulresso will be available through Risk Evaluation...

Recent Posts

  • What Is a DNP? Everything You Need to Know About the Doctor of Nursing Practice
  • Halloween Health & Safety: Tips for Families and Clinicians
  • Exploring a Career in Nursing: What You Need to Know
  • Back-to-School Wellness — A Resource for Families and Providers
  • The Summer Injury Spike: Common ER Visits and How to Prevent Them

Categories

  • Alerts
  • Emergency Medicine
  • Featured Posts
  • Nursing
  • Pharmacy
  • Press & Media
  • Primary Care
  • Uncategorized
PEPID, LLC. All rights reserved